WILLIS-KNIGHTON HEALTH SYSTEMS
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.1M
- Transactions
- 227
- Companies
- 39
- Average per transaction
- $9,308
Who reported the payments
| GSK | $796,551 |
| Kls-martin L.p. | $321,980 |
| AstraZeneca | $202,619 |
| Seagen Inc. | $192,659 |
| AbbVie | $88,592 |
| Bluewind Medical | $71,314 |
| Bristol Myers Squibb | $63,242 |
| Ortho-clinical Diagnostics, Inc. | $48,800 |
| Clearpoint Neuro, Inc. | $47,244 |
| Incyte Corporation | $32,654 |
| Astrazeneca AB | $27,206 |
| Medartis Inc. | $25,895 |
| Novocure Inc. | $25,740 |
| E.r. Squibb & Sons, L.L.C. | $22,382 |
| Boston Scientific | $20,512 |
| Rapid Medical Ltd | $16,500 |
| Bard Peripheral Vascular, Inc. | $14,947 |
| Remel, Inc. | $13,750 |
| Pfizer | $13,500 |
| Astrazeneca UK Limited | $13,472 |
| Takeda Pharmaceuticals U.S.A., Inc. | $12,500 |
| Axonics, Inc. | $8,500 |
| Siemens Medical Solutions USA, Inc. | $7,408 |
| KARL Storz Endoscopy-america | $6,740 |
| Sterilmed, Inc. | $5,118 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $3,600 |
| Organon | $2,800 |
| Pharmacyclics LLC, An Abbvie Company | $1,600 |
| Welch Allyn | $1,151 |
| Stryker | $1,099 |
| BD | $874 |
| Hikma Pharmaceuticals USA | $712 |
| Baxter Healthcare | $494 |
| Bio-rad Laboratories, Inc. | $427 |
| Abbott | $145 |
| SPS Medical Supply Corp. | $99 |
| Eli Lilly | $76 |
| Olympus America Inc. | $20 |
| Genmark Diagnostics, Inc. | $16 |